Maryland State Retirement & Pension System Cytokinetics Inc Transaction History

Maryland State Retirement & Pension System

$4.65 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$26.88 - $83.49 $7,472 - $23,210	278 Added 0.79%	35,637 $2.98 Million
Q3 2023 Oct 23, 2023	SELL	$29.46 - $36.61 $56,062 - $69,668	-1,903 Reduced 5.11%	35,359 $1.04 Million
Q2 2023 Jul 10, 2023	SELL	$32.62 - $40.75 $27,596 - $34,474	-846 Reduced 2.22%	37,262 $1.22 Million
Q1 2023 Apr 20, 2023	SELL	$33.36 - $45.71 $27,155 - $37,207	-814 Reduced 2.09%	38,108 $1.34 Million
Q4 2022 Jan 17, 2023	BUY	$35.77 - $51.11 $15,166 - $21,670	424 Added 1.1%	38,922 $0
Q3 2022 Oct 28, 2022	BUY	$38.54 - $54.52 $146,066 - $206,630	3,790 Added 10.92%	38,498 $1.87 Million
Q2 2022 Aug 01, 2022	BUY	$33.93 - $48.92 $36,339 - $52,393	1,071 Added 3.18%	34,708 $1.36 Million
Q1 2022 Apr 11, 2022	BUY	$29.74 - $46.0 $5,829 - $9,016	196 Added 0.59%	33,637 $1.24 Million
Q4 2021 Feb 09, 2022	BUY	$34.35 - $46.38 $32,323 - $43,643	941 Added 2.9%	33,441 $1.52 Million
Q3 2021 Oct 29, 2021	BUY	$18.54 - $35.74 $602,550 - $1.16 Million	32,500 New	32,500 $1.12 Million

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

Black Rock Inc. New York, NY

14.7M
Shares

$717 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$575 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

9.69M
Shares

$474 Million
0.31% of portfolio
Wellington Management Group LLP Boston, MA

7.77M
Shares

$380 Million
0.07% of portfolio
State Street Corp Boston, MA

6.46M
Shares

$316 Million
0.01% of portfolio

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland State Retirement & Pension System, based on Form 13F filings with the SEC.

News

Stay updated on Maryland State Retirement & Pension System with notifications on news.

Account